The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The China maternity goods market size reached US$ 20.81 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 13.6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Maternity goods are utilized by women during pregnancy and the postpartum stage. They generally include clothing items, health care goods and skincare products. At present, there is a rise in the demand for maternity goods in the People’s Republic of China. This can be accredited to rapid urbanization, inflating income levels and a huge population. Besides this, the rising awareness about the complexities in childbirth and fertility issues are boosting the sales of these products in the country.
Introduced in 1979, the one-child policy was a part of the birth planning program that was designed to control the size of the rapidly growing population in China. However, the Government of China announced a relaxation and replaced it with the two-child policy in 2015. Consequently, there is a significant rise in the birth rate, which, in turn, has increased the demand for maternity goods in the country. Apart from this, the growing number of working women and the escalating demand for maternity goods during the prenatal and postnatal stages is also strengthening the market growth. Furthermore, owing to the strong influence of social media platforms and the increasing awareness among individuals about the harmful effects of chemicals, the demand for natural and organic maternity skincare products is increasing. Therefore, some of the leading players are introducing organic product variants. They are also investing in various promotional campaigns to expand their existing consumer base. Moreover, on account of the continuously increasing popularity of e-commerce platforms, these players are selling their products through different online distribution channels.
IMARC Group provides an analysis of the key trends in each sub-segment of the China maternity goods market, along with forecasts at the country and province level from 2021-2026. Our report has categorized the market based on duration, product type and distribution channel.
Breakup by Duration:
At present, maternity goods for the postnatal period exhibit a clear dominance in the market.
Breakup by Product Type:
Nutrients and health care products account for the majority of the total market share.
Breakup by Distribution Channel:
Maternity goods are usually sold through supermarkets and hypermarkets in China.
Breakup by Province:
Guangdong province currently enjoys the leading position in the market.
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are:
Maternity Nutrients and Healthcare Key Players:
Maternity Wear Key Players:
Maternity Skin Care Key Players:
|Base Year of the Analysis||2020|
|Segment Coverage||Duration, Product Type, Distribution Channel, Province|
|Province Covered||Guangdong, Jiangsu, Zhejiang, Henan, Sichuan|
|Companies Covered||Health and Happiness (H&H) International Holdings Limited, Tomson Group Limited, Real Nutriceutical Group Limited, Shanghai October Mommy Network Co., Ltd, Happy House Company, Mum &me, Nanchang Jingqi Clothing Co., Ltd., Kangaroo Mother, Pro Run and Pigeon Corporation|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License $ 1999
Five User License $ 2999
Corporate License $ 3999
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
Swine Healthcare Market by Product (Diagnostic Tests, Therapeutics), Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Others), Route of Administration (Injectable, Oral), Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Online Pharmacy), and Region 2023-2028
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Others), and Region 2023-2028
Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Gastric Cancer Drugs Market by Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Route of Administration (Oral, Parenteral), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at